26th May 2021 10:33
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 25 May 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
328,104 | 10.7169 GBP | 10.5700 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
170,903 | 10.7300 GBP | 10.5800 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a Long Position
Opening a Short Position
| 485 49,448 3,693 484 1,758 154 397 5,940 4,876 2,844
2,229 3,700 5,556 200 4,156
3,895 44,956 5,888 130 1,493 4 716 6,278 16,282 10,704 2,239 918 205
15,000 40,308 2,368 2,468 205 2,249
1,704 798
2,502 135,000 | 10.5861 GBP 10.5900 GBP 10.5902 GBP 10.5905 GBP 10.6039 GBP 10.6101 GBP 10.6203 GBP 10.6306 GBP 10.6315 GBP 10.6352 GBP
10.5977 GBP 10.5978 GBP 10.6233 GBP 10.6800 GBP 10.7275 GBP
10.5900 GBP 10.5904 GBP 10.6166 GBP 10.6175 GBP 10.6183 GBP 10.6200 GBP 10.6238 GBP 10.6268 GBP 10.6325 GBP 10.6386 GBP 10.6387 GBP 10.6425 GBP 10.6882 GBP
10.5969 GBP 10.6029 GBP 10.6302 GBP 10.6319 GBP 10.6702 GBP 10.6831 GBP
10.6106 GBP 10.6170 GBP
10.6013 GBP 10.6334 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 26 May 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L